EUVIMEDEUVIMED entdecken
LeserbriefFallbericht

Dapsone as a Steroid‐Sparing Therapy for Refractory Reactive T‐Cell‐Rich Lymphoid Proliferation: A Case Report

Manoj Bhagwat iD, Joshua Mijares iD, Alexandra Flamm iD, Vignesh Ramachandran iD

The Journal of Dermatology · 2026-11 · 53 (11)

DOI: 10.1111/1346-8138.70480 ↗

Kurz gefasst

Leserbrief in der Zeitschrift The Journal of Dermatology, online erschienen am 25.08.2026. Verfasst von Manoj Bhagwat und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana, USA. Die Arbeit nennt 3 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York, USA.

ORCID-Profile: Manoj Bhagwat, Joshua Mijares, Alexandra Flamm, Vignesh Ramachandran

Zitieren

APA

Bhagwat, M., Mijares, J., Flamm, A., & Ramachandran, V. (2026). Dapsone as a Steroid‐Sparing Therapy for Refractory Reactive T‐Cell‐Rich Lymphoid Proliferation: A Case Report. The Journal of Dermatology, 53(11). https://doi.org/10.1111/1346-8138.70480

Vancouver

Bhagwat M, Mijares J, Flamm A, Ramachandran V. Dapsone as a Steroid‐Sparing Therapy for Refractory Reactive T‐Cell‐Rich Lymphoid Proliferation: A Case Report. The Journal of Dermatology. 2026;53(11). doi:10.1111/1346-8138.70480

BibTeX
@article{Bhagwat2026,
  author = {Bhagwat, Manoj and Mijares, Joshua and Flamm, Alexandra and Ramachandran, Vignesh},
  title = {Dapsone as a Steroid‐Sparing Therapy for Refractory Reactive T‐Cell‐Rich Lymphoid Proliferation: A Case Report},
  journal = {The Journal of Dermatology},
  year = {2026},
  volume = {53},
  number = {11},
  doi = {10.1111/1346-8138.70480}
}
Kostenlos starten →